Login Register Cart 0
Generic placeholder image

Recent Patents on Biotechnology

Editor-in-Chief

ISSN (Print): 1872-2083
ISSN (Online): 2212-4012

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Potential Action of Lactobacillus Probiotics Against Fungi of the Genus Candida: A Bibliographic Review

Author(s): Milton Marcus Neves Sousa Carneiro Pimentel, Janaína de Carvalho Alves*, Lúcio Henrique Sousa Pinheiro and Mariana Nougalli Roselino

Volume 17, Issue 3, 2023

Published on: 10 November, 2022

Page: [198 - 205] Pages: 8

DOI: 10.2174/1872208317666221027093644

Price: $65

Abstract

Background: The use of Lactobacillus probiotics may confer beneficial effects on an individual’s health, such as the ability to act against fungi of the genus Candida. There are about 200 species of those yeasts, and they can develop candidiasis infections, which affect about 75% of adult women.

Objective: This study aimed to raise articles that investigated the potential action of several Lactobacillus strains in front of Candida species.

Methods: For this review, 15 articles published between 2015 and 2020 were studied.

Results: The results showed the Lactobacillus species L. paracasei, L. acidophilus, L. helveticus, L. rhamnosus, L. reuteri, and L. gasseri have the potential action to inhibit the growth and quantity of colony-forming units of Candida species in vitro studies. Further, they can reduce the rate of candidiasis recurrence and increase the cure rate, mainly when associated with traditional pharmacotherapy, as observed in vivo studies.

Conclusion: The time of use and the strain of Lactobacillus probiotics can also be determining factors for the efficiency in the treatment against Candida species, suggesting that a long time of use of Lactobacillus probiotics is directly associated with a better result.

« Previous Next »
Graphical Abstract

[1]
It provides for the updating of constituent lists, limits of use, claims and complementary labelling of food supplements. Official Gazette of the Union. 2020. Available from: http://antigo.anvisa.gov.br/documents/ 10181/5809185/IN_76_2020_.pdf/dfd37f9a-678f- 4d04-86e7-d44a8ee9490b
[2]
Collado MC, Gueimonde M, Martinez G. Current and future applications of probiotics. Curr Nutr Food Sci 2011; 7: 170-80.
[http://dx.doi.org/10.2174/157340111797264877]
[3]
World Gastroenterology Organisation Global Guidelines. Probiotics and prebiotics. 2017. Available from: https://www.worldgastroenterology.org/guidelines/gl obal-guidelines/probiotics-and-prebiotics/probioticsand- prebiotics-english
[4]
Álvares CA, Svidzinski TIE, Consolaro MEL. Vulvovaginal candidiasis: Predisposing factors of the host and virulence of yeasts. J Bras Patol Med Lab 2007; 43(5): 319-27.
[5]
Barbedo LM, Sgarbi DBG. Candidiasis. DST J Bras 2010; 22: 22-83.
[6]
Parolin C, Marangoni A, Laghi L. Isolation of vaginal Lactobacilli and characterization of anti-candida activity. PLoS One 2015; 10(6): e0131220.
[http://dx.doi.org/10.1371/journal.pone.0131220]
[7]
Kovachev SM, Dobrevska RS. Local probiotic therapy for vaginal Candida albicans infections. Probiotics Antimicrob Proteins 2015; 7(1): 38-44.
[http://dx.doi.org/10.1007/s12602-014-9176-0] [PMID: 25362524]
[8]
Aarti C, Khusro A, Varghese R, et al. In vitro investigation on probiotic, anti-candida, and antibiofilm properties of Lactobacillus pentosus strain LAP1. Arch Oral Biol 2018; 89: 99-106.
[http://dx.doi.org/10.1016/j.archoralbio.2018.02.014] [PMID: 29499562]
[9]
Fluconazole. Brazil: Geo lab Pharmaceutical Industry 2018. Available from: https://www.medicines.org.uk/ emc/product/6086/smpc#gref
[10]
Current approach to vulvovaginal candidiasis. DST J Bras 2001; 13(4): 3-5.
[11]
Study of the applicability of the total protein quantification assay in SIRC cells in the evaluation of the potential for eye irritation of shampoos and tensoactives. Thesis (Master) - Oswaldo Cruz Foundation, Sérgio Arouca National School of Public Health Rio de Janeiro 2006.
[12]
Kang CH, Kim Y, Han SH, Kim JS, Paek NS, So JS. In vitro probiotic properties of vaginal Lactobacillus fermentum MG901 and Lactobacillus plantarum MG989 against Candida albicans. Eur J Obstet Gynecol Reprod Biol 2018; 228: 232-7.
[http://dx.doi.org/10.1016/j.ejogrb.2018.07.005] [PMID: 30014929]
[13]
Santos CMA, Pires MCV, Leão TL, et al. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment. Microbiology 2016; 162(7): 1195-207.
[http://dx.doi.org/10.1099/mic.0.000302] [PMID: 27154285]
[14]
Beck BR, Park GS, Lee YH, Im S, Jeong DY, Kang J. Whole genome analysis of Lactobacillus plantarum strains isolated from Kimchi and determination of probiotic properties to treat mucosal infections by Candida albicans and Gardnerella vaginalis. Front Microbiol 2019; 10: 433.
[http://dx.doi.org/10.3389/fmicb.2019.00433]
[15]
Coman MM, Verdenelli MC, Cecchini C, et al. In vitro evaluation on HeLa cells of protective mechanisms of probiotic lactobacilli against Candida clinical isolates. J Appl Microbiol 2015; 119(5): 1383-90.
[http://dx.doi.org/10.1111/jam.12947] [PMID: 26335148]
[16]
Carmo MS, Noronha FMF, Arrruda MO, et al. Lacobacillus fermentum ATCC 23271 displays in vitro inhibitory activities against Candida spp. Front Microbiol 2016; 7: 1722.
[17]
Wang S, Wang Q, Yang E, Yan L, Li T, Zhuang H. Antimicrobial compounds produced by vaginal Lactobacillus crispatus are able to strongly inhibit Candida albicans growth, hyphal formation and regulate virulence-related gene expressions. Front Microbiol 2017; 8: 564.
[18]
Kumherová M, Veselá K, Kosová K, Mašata J, Horáčková Š, Šmidrkal J. Novel potential probiotic Lactobacilli for prevention and treatment of vulvovaginal infections. Probiotics Antimicrob Proteins 2020; 13(1): 163-72.
[19]
Deida F, Amorouso A, Allesina S, et al. In vitro activity of Lactobacillus fermentum LF5 against different Candida species and Gardnerella vaginalis, a new perspective to approach mixed vaginal infections. Proceedings from the 8th probiotics, prebiotics & new foods for microbiota and human health meeting held in Rome, Italy on September 13-15. J Clin Gastroenterol 2015; S168-70.
[20]
Liao H, Liu S, Wang H, Su H, Liu Z. Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus caseiin the murine model of vulvovaginal candidiasis. BMC Microbiol 2019; 19: 7.
[21]
Davar R, Nokhostin F, Eftekhar M, Sekhavat L, Zadeh MB, Shamsi F. Comparing the recurrence of vulvovaginal Candidiasis in patients undergoing prophylactic treatment with probiotic and placebo during the 6 months. Probiotics Antimicrob Proteins 2016; 8(3): 130-3.
[22]
Russo R, Superti F, Karadja E, De Seta F. Randomised clinical trial in women with recurrent vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment. Mycoses 2019; 62(4): 328-35.
[http://dx.doi.org/10.1111/myc.12883] [PMID: 30565745]
[23]
Leão MVP, Tavares TAA, Gonçalves e Silva CR, et al. Lactobacillus rhamnosus intake can prevent the development of Candidiasis. Clin Oral Investig 2018; 22(7): 2511-8.
[http://dx.doi.org/10.1007/s00784-018-2347-8] [PMID: 29372447]
[24]
Li T, Liu Z, Zhang X, Chen X, Wang S. Probiotic Lactobacillus crispatus and Lactobacillus delbrueckii exhibit strong antifungal effects against vulvovaginal candidiasis in a rat model. Front Microbiol 2019; 2019: 01033.
[http://dx.doi.org/10.3389/fmicb.2019.01033]
[25]
Rossoni RD, de Barros PP, de Alvarenga JA, et al. Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: Identification of potential probiotic candidates to prevent oral candidiasis. Biofouling 2018; 34(2): 212-25.
[http://dx.doi.org/10.1080/08927014.2018.1425402] [PMID: 29380647]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy